Trial Details
TERMINATEDBasic Information
| Clinical ID | c1221 |
|---|---|
| Identifier | NCT01805791 |
| Trial Title | A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: HMPL-004 1800 mg/day|DRUG: Placebo|DRUG: HMPL-004 2400 mg/day |
Participant Information
| Sponsor | Hutchison Medipharma Limited |
|---|---|
| City | Agawam |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-03-13 |
|---|---|
| Primary Completion Date | 2025-10-14 |
| Completion Date | 2025-10-14 |